{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:07:18Z","timestamp":1790521638428,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00381-014-2401-z","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T08:17:24Z","timestamp":1397031444000},"page":"2051-2061","source":"Crossref","is-referenced-by-count":27,"title":["The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma"],"prefix":"10.1007","volume":"30","author":[{"given":"Stanislaw R.","family":"Burzynski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J.","family":"Janicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Burzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania","family":"Marszalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"key":"2401_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet 7:241\u2013248","journal-title":"Lancet"},{"key":"2401_CR2","unstructured":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009 (2012). Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, 14:201. http:\/\/neuro-oncology.oxfordjournals.org\/content\/14\/suppl_5\/v1.extract"},{"key":"2401_CR3","first-page":"379","volume":"5","author":"SR Burzynski","year":"2007","unstructured":"Burzynski SR (2007) Recent clinical trials in diffuse intrinsic brainstem glioma. Cancer Ther 5:379\u2013390","journal-title":"Cancer Ther"},{"key":"2401_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"D-A Khuong-Quang","year":"2012","unstructured":"Khuong-Quang D-A, Buczkowicz P, Rakopoulos P, Liu X-Y, Fontebasso AM et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439\u2013447","journal-title":"Acta Neuropathol"},{"key":"2401_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1534735403261964","volume":"3","author":"SR Burzynski","year":"2004","unstructured":"Burzynski SR (2004) The present state of antineoplaston research (1). Integr Cancer Ther 3:47\u201358","journal-title":"Integr Cancer Ther"},{"key":"2401_CR6","volume-title":"Brain cancer: therapy and surgical interventions","author":"SR Burzynski","year":"2006","unstructured":"Burzynski SR (2006) Targeted therapy for brain tumors. In: Yang A (ed) Brain cancer: therapy and surgical interventions. Nova Science Publishers, New York"},{"key":"2401_CR7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4236\/jct.2012.33028","volume":"3","author":"SS Patil","year":"2012","unstructured":"Patil SS, Burzynski SR, Mrowczynski E, Grela K, Chittur S (2012) Phenylacetylglutaminate in combination with phenylacetate causes cell cycle blockade and apoptosis by upregulating VDUP1 in U-87 glioblastoma cells. J Cancer Ther 3:192\u2013200","journal-title":"J Cancer Ther"},{"key":"2401_CR8","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1038\/sj.onc.1206610","volume":"22","author":"SH Han","year":"2003","unstructured":"Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, Yang Y, Lee KN, Choi I (2003) VDUP1 upregulated by TGF-\u03b21 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22:4035\u20134046","journal-title":"Oncogene"},{"key":"2401_CR9","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.0800293105","volume":"105","author":"STY Hui","year":"2008","unstructured":"Hui STY, Andres AM, Miller AK, Spann NJ, Potter DW, Post NM, Chen AZ, Sachithanantham S, Jung DY, Kim JK, Davis RA (2008) Txnip balances metabolic and growth signaling via PTEN disulfide reduction. PNAS 105:3921\u20133926","journal-title":"PNAS"},{"key":"2401_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/neuonc\/nop026","volume":"12","author":"H Mure","year":"2010","unstructured":"Mure H, Matsuzaki K, Kitazato KT, Mizobuchi Y, Kuwayama K, Kageji T, Nagahiro S (2010) Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro-Oncol 12:221\u2013232","journal-title":"Neuro-Oncol"},{"key":"2401_CR11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","volume":"12","author":"AP Gilmore","year":"2005","unstructured":"Gilmore AP (2005) Anoikis. Cell Death Differ 12:1473\u20131477","journal-title":"Cell Death Differ"},{"key":"2401_CR12","first-page":"16","volume":"2","author":"BB Zhou","year":"2003","unstructured":"Zhou BB, Anderson HJ, Roberge M (2003) Targeting DNA checkpoint kinases in cancer therapy. Cancer Biol Ther 2:16\u201322","journal-title":"Cancer Biol Ther"},{"issue":"5442","key":"2401_CR13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.286.5442.1166","volume":"286","author":"Y Sanchez","year":"1999","unstructured":"Sanchez Y, Bachant J, Wang H, Hu F, Liu D, Tetzlaff M et al (1999) Control of the DNA damage checkpoint by Chk1 and Rad53 protein kinases through distinct mechanisms. Science 286(5442):1166\u20131171","journal-title":"Science"},{"key":"2401_CR14","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-07-5656","volume":"68","author":"VL Gabai","year":"2008","unstructured":"Gabai VL, O\u2019Callaghan-Sunol C, Meng L, Sherman MY, Yaglom J (2008) Triggering senescence programs suppresses Chk1 kinase and sensitizes cells to genotoxic stresses. Cancer Res 68:1834\u20131842","journal-title":"Cancer Res"},{"key":"2401_CR15","doi-asserted-by":"crossref","first-page":"ii87","DOI":"10.1093\/neuonc\/nop017","volume":"12","author":"S Patil","year":"2010","unstructured":"Patil S, Burzynski SR, Mrowczynski E, Grela K (2010) Antineoplastons initiate caspase induced apoptosis by suppressing survivin expression in U87 glioblastoma cells. Neuro-Oncol 12:ii87","journal-title":"Neuro-Oncol"},{"key":"2401_CR16","first-page":"iv10","volume":"12","author":"S Patil","year":"2010","unstructured":"Patil S, Burzynski SR, Mrowczynski E, Grela K (2010) CB-15. Targeting microRNAs in glioma cells with antineoplastons. Neuro-Oncol 12:iv10","journal-title":"Neuro-Oncol"},{"key":"2401_CR17","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, Saba da Silva N, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999\u20134006","journal-title":"J Clin Oncol"},{"key":"2401_CR18","first-page":"3620","volume":"9","author":"RJ Gilbertson","year":"2003","unstructured":"Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J, Gaijar A, Rush L, Hamilton RL, Finkelstein SD, Pollack IF (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9:3620\u20133624","journal-title":"Clin Cancer Res"},{"key":"2401_CR19","first-page":"47","volume":"12","author":"SR Burzynski","year":"1986","unstructured":"Burzynski SR, Kubove E (1986) Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 12:47\u201355","journal-title":"Drugs Exp Clin Res"},{"key":"2401_CR20","volume-title":"Recent advances in chemotherapy","author":"SR Burzynski","year":"1992","unstructured":"Burzynski SR, Kubove E, Burzynski B (1992) Phase II clinical trials of antineoplastons A10 and AS2-1 infusions in astrocytoma. In: Adam D (ed) Recent advances in chemotherapy. Futuramed Publishers, Munich"},{"key":"2401_CR21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/jnci\/84.22.1699","volume":"84","author":"MG Hawkins","year":"1992","unstructured":"Hawkins MG, Friedman MA (1992) National Cancer Institute\u2019s evaluation of unconventional cancer treatments. J Natl Cancer Inst 84:1699","journal-title":"J Natl Cancer Inst"},{"key":"2401_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-199918010-00001","volume":"18","author":"SR Burzynski","year":"1999","unstructured":"Burzynski SR, Conde AB, Peters A, Saling B, Ellithorpe R, Daugherty JP, Nacht CH (1999) A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumours. Clin Drug Investig 18:1\u201310","journal-title":"Clin Drug Investig"},{"key":"2401_CR23","doi-asserted-by":"crossref","unstructured":"Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A (2014) Long term survival (>13\u00a0years) in a child with recurrent diffuse pontine gliosarcoma: a case report. J Pediatr Hematol Oncol. doi: 10.1097\/MPH.0000000000000020","DOI":"10.1097\/MPH.0000000000000020"},{"key":"2401_CR24","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/1097-0142(19930815)72:4<1414::AID-CNCR2820720442>3.0.CO;2-C","volume":"72","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Boyett JM, Zimmerman RA et al (1993) Hyperfractionated radiation therapy (72\u00a0Gy) for children with brain stem gliomas. A Children\u2019s Cancer Group Phase I\/II Trial. Cancer 72:1414\u20131421","journal-title":"Cancer"},{"key":"2401_CR25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1227\/00006123-199312000-00010","volume":"33","author":"AL Albright","year":"1993","unstructured":"Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children\u2019s Cancer Group. Neurosurgery 33:1026\u20131030","journal-title":"Neurosurgery"},{"key":"2401_CR26","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in Neuro-oncology Working Group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"2401_CR27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.1999.17.3.984","volume":"17","author":"SM Chang","year":"1999","unstructured":"Chang SM et al (1999) Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol 17:984\u2013990","journal-title":"J Clin Oncol"},{"key":"2401_CR28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/nos273","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma\u2014are we there yet? Neuro Oncol 15:4\u201327","journal-title":"Neuro Oncol"},{"key":"2401_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00148581-200608030-00003","volume":"8","author":"SR Burzynski","year":"2006","unstructured":"Burzynski SR (2006) Treatments for astrocytic tumors in children: current and emerging strategies. Pediatr Drugs 8:167\u2013168","journal-title":"Pediatr Drugs"},{"key":"2401_CR30","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1200\/JCO.2002.08.141","volume":"20","author":"LS Lashford","year":"2002","unstructured":"Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D et al (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children\u2019s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684\u20134691","journal-title":"J Clin Oncol"},{"key":"2401_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1215\/S115285170200056X","volume":"5","author":"ZE Dreyer","year":"2003","unstructured":"Dreyer ZE, Kadota RP, Stewart CF, Friedman HS, Mahoney DH et al (2003) Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. Neuro Oncol 5:261\u2013267","journal-title":"Neuro Oncol"},{"key":"2401_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-005-0172-7","volume":"58","author":"K Warren","year":"2006","unstructured":"Warren K, Jakacki R, Widemann B, Aikin A, Libucha M et al (2006) Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children\u2019s Oncology Group. Cancer Chemother Pharmacol 58:343\u2013347","journal-title":"Cancer Chemother Pharmacol"},{"key":"2401_CR33","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/cncr.23078","volume":"110","author":"M Fouladi","year":"2007","unstructured":"Fouladi M, Nicholson HS, Zhou T, Laningham F, Helton KJ et al (2007) A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma\/primitive neuroectodermal tumor, or brainstem glioma: a Children\u2019s Oncology Group study. Cancer 110:2535\u20132541","journal-title":"Cancer"},{"issue":"28","key":"2401_CR34","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2009.26.8789","volume":"2010","author":"S Gururangan","year":"2010","unstructured":"Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ et al (2010) Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol 2010(28):3069\u20133075","journal-title":"J Clin Oncol"},{"key":"2401_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pbc.22690","volume":"56","author":"JE Minturn","year":"2011","unstructured":"Minturn JE, Janss AJ, Fisher PG, Allen JC, Patti R et al (2011) A phase II study of metronomic oral topotecan for recurrent childhood brain tumors. Pediatr Blood Cancer 56:39\u201344","journal-title":"Pediatr Blood Cancer"},{"key":"2401_CR36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11060-011-0709-z","volume":"106","author":"KE Warren","year":"2012","unstructured":"Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY et al (2012) A phase II study of 06-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain tumor Consortium study. J Neurooncol 106:643\u2013649","journal-title":"J Neurooncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-014-2401-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-014-2401-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-014-2401-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T10:23:46Z","timestamp":1565346226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-014-2401-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2401"],"URL":"https:\/\/doi.org\/10.1007\/s00381-014-2401-z","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,10]]}}}